Trials / Completed

CompletedNCT00002054

A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Fisons · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To evaluate the safety, tolerability, and description of time to Pneumocystis carinii pneumonia (PCP) for long-term biweekly administration of 1 of 2 doses of aerosol pentamidine when used as a prophylactic agent in patients who have had one episode of AIDS-associated PCP.

Conditions

Pneumonia, Pneumocystis Carinii
HIV Infections

Interventions

Type	Name	Description
DRUG	Pentamidine isethionate

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00002054. Inclusion in this directory is not an endorsement.